When it was announced that Jon Jones would be allowed to fight at UFC 232 in California, despite trace amounts of turinabol turning up on several of his recent drug tests, several of his fellow fighters piped up, questioning the integrity of the UFC and the United States Anti-Doping Agency (USADA). Jones’s arch rival Daniel Cormier was one of the first to do so, and now, fan favorite lightweight contender Nate Diaz has done the same.
Apparently, Nate Diaz no longer plans on opening his door when USADA comes to collect samples.
Usada can’t come over anymore..
— Nathan Diaz (@NateDiaz209) December 28, 2018
“USADA can’t come over anymore..” Nate Diaz wrote on Twitter.
Nate Diaz has not fought since August of 2016, when he gave up a close, majority decision to Conor McGregor. The Stockton, California native was expected to return to the cage against Dustin Poirier at UFC 230 in November, but this plan was scrapped when Poirier sustained an unfortunate injury.
Since then, there’s been widespread wonder as to whether Nate Diaz will ever fight again. If he does, he’ll have to answer when USADA knocks, as the UFC will reportedly extend its relationship with the anti-doping organization, and boost the amount of testing it undertakes.
“USADA came to us and said, ‘hey, we think you should up the amount of testing that you are doing,’ So we just renewed the contract with USADA and we are increasing our testing numbers between 30 to 40 percent,” UFC exec Jeff Novitzky said on the Joe Rogan Experience podcast. “Currently, the first three years of the program under contract were approximately 700 tests and starting this next year we are going to up that to around 4300-4400 tests. It’s going to be more of a burden, there is going to be USADA showing up at more doorsteps early in the morning for more of our athletes but I think this is a perfect example that that increased volume in the testing can actually be a protection to the athlete.”
What do you think of this comment from Nate Diaz?
This article first appeared on BJPENN.COM on 12/28/2018.